S3F0 (S3F0) News
Track canonical SquawkNews coverage tagged to S3F0, S3F0. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Switzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Sep 30, 2026, 05:11 AM UTC
H
Santhera Pharmaceuticals Holding AG (S3F0) H1 Revenue CHF 48.3M; Guides CHF 80—90M FY
Santhera reported H1 2026 revenue of CHF 48.3M and a net loss of CHF -21.5M, and reiterated 2026 revenue guidance of CHF 80—90M with opex of CHF 50—55M.Material DetailsContext by AI AnalystThis is mid-cycle confirmation
EARNINGS | Sep 30, 2026, 05:01 AM UTC